SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Open-market buys and sells only — the deliberate trades. Zero here doesn’t mean no filings: grants, option exercises and tax withholding (below) are compensation, not market trades.
| Insider | Role | Date | Transaction | Shares | Value |
|---|---|---|---|---|---|
| Micallef Andrew | EVP, Chief Operations Officer | 2026-06-15 | Open-market sell 10b5-1 | 1000 | $316K |
| CLAYTON ANNETTE K | Director | 2026-06-10 | Option exercise | 1035 | $0 |
| CLAYTON ANNETTE K | Director | 2026-06-10 | Tax withholding | 513 | $153K |
| Chunyuan Gu | Director | 2026-06-10 | Option exercise | 1035 | $0 |
| Chunyuan Gu | Director | 2026-06-10 | Tax withholding | 418 | $124K |
| Foxx Anthony R | Director | 2026-06-10 | Option exercise | 1035 | $0 |
| Foxx Anthony R | Director | 2026-06-10 | Tax withholding | 513 | $153K |
| GAVRIELOV MOSHE | Director | 2026-06-10 | Option exercise | 1035 | $0 |
| GAVRIELOV MOSHE | Director | 2026-06-10 | Tax withholding | 426 | $127K |
| Olving Lena | Director | 2026-06-10 | Option exercise | 1035 | $0 |
| Olving Lena | Director | 2026-06-10 | Tax withholding | 513 | $153K |
| SUMME GREGORY L | Director | 2026-06-10 | Option exercise | 1035 | $0 |
| SUMME GREGORY L | Director | 2026-06-10 | Tax withholding | 513 | $153K |
| Southern Julie | Director | 2026-06-10 | Option exercise | 1035 | $0 |
| Southern Julie | Director | 2026-06-10 | Tax withholding | 513 | $153K |
| Staiblin Jasmin | Director | 2026-06-10 | Option exercise | 1035 | $0 |
| Staiblin Jasmin | Director | 2026-06-10 | Tax withholding | 513 | $153K |
| Sundstrom Karl-Henrik | Director | 2026-06-10 | Option exercise | 1035 | $0 |
| Sundstrom Karl-Henrik | Director | 2026-06-10 | Tax withholding | 513 | $153K |
| Jensen Christopher L | EVP, Chief People Officer | 2026-06-01 | Open-market sell 10b5-1 | 1746 | $553K |
Fiscal period ending 2025-12-31 versus 2024-12-31 — view filing on EDGAR →
Tariff escalation and trade restrictions now carry concrete, named operational and financial consequences for semiconductor supply chains — a material step beyond prior inflation-only framing. Risk exposure broadened across macro, supply chain, and M&A dimensions simultaneously, with no offsetting easing. The addition of software defect liability and explicit government approval risk for acquisitions further widens the company's vulnerability profile.
2 company-specific · 3 common-mode
Company now explicitly discloses software-enabled products and software defect risks, expanding product liability exposure beyond hardware semiconductors to include software vulnerabilities and updates.
Our business may be adversely affected by costs relating to product defects, and we could be faced with product liability and warranty claims. We make highly complex electronic components which in…
New disclosure of government approval risk for acquisitions. Prior year omitted regulatory delay/denial risk; now explicitly flagged as material M&A impediment.
We may engage in acquisitions and other strategic transactions or make investments, or be unable to consummate planned strategic acquisitions, which could adversely affect our results of operations.…
New disclosure of concrete 2025 tariff impacts and ongoing trade investigations with direct operational and financial consequences for semiconductor supply chains and costs.
Recently announced and future tariffs and other trade restrictions could materially and adversely affect our business, financial condition and results of operations. In 2025, the U.S. government…
New disclosure of 2023-2025 demand softening and geopolitical uncertainty. Shifts from historical examples to current/recent adverse conditions affecting end markets.
Significantly increased volatility and instability and unfavorable economic conditions may adversely affect our business. It is difficult for us, our customers and suppliers, to forecast demand…
Added explicit disclosure of tariff and trade restriction risks as material cost and availability drivers, escalating supply chain vulnerability beyond prior inflation-only framing.
We rely on the timely supply of equipment and materials and could suffer if suppliers fail to meet their delivery obligations or raise prices. Certain equipment and materials needed in our…
NXP B.V. entered into a $250 million unsecured senior loan facility agreement with the European Investment Bank on September 1, 2026, creating a new direct financial obligation with a six-year maximum tenor, guaranteed by the parent company and subsidiaries, to fund capital expansion of semiconductor manufacturing capacity in Malaysia.
View raw filing on EDGAR →The Board of Directors approved payment of an interim dividend of $1.014 per ordinary share for Q3 2026, payable October 8, 2026. This is a straightforward dividend distribution disclosure, explicitly described as part of NXP's "ongoing capital return program" and reflecting the board's confidence in the company's capital structure and cash flow generation. The amount and payment date are clearly specified.
View raw filing on EDGAR →NXP issued a press release on July 28, 2026, disclosing second quarter 2026 financial results, including revenue of $3.5 billion (up 19% year-on-year), GAAP diluted EPS of $3.02, and non-GAAP diluted EPS of $3.61, along with third-quarter guidance. This is a standard quarterly earnings release attached as Exhibit 99.1 and disclosed under Item 2.02 (Results of Operations and Financial Condition).
View raw filing on EDGAR →NXP held its 2026 Annual General Meeting on June 10, 2026, with shareholders voting on 11 resolutions including adoption of annual accounts, director re-appointments, board authorizations, auditor re-appointment, and executive compensation approvals. Detailed vote tallies (For/Against/Abstain/Broker Non-Votes) for each resolution were disclosed.
View raw filing on EDGAR →The Board approved an interim dividend of $1.014 per ordinary share payable in July 2026, representing a direct return of capital to shareholders.
View raw filing on EDGAR →